Status:

UNKNOWN

Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL)

Lead Sponsor:

Ospedale Santa Croce-Carle Cuneo

Collaborating Sponsors:

GITIL (GRUPPO ITALIANO TERAPIE INNOVATIVE NEI LINFOMI)

Consorzio Mario Negri Sud

Conditions:

HODGKIN LYMPHOMA

Eligibility:

All Genders

18-60 years

Phase:

PHASE2

Brief Summary

The purpose of this multicenter clinical trial is to assess the clinical impact of dose intensification performed very early during treatment in a subset of poor prognosis, advanced-stage Hodgkin Lymp...

Detailed Description

Version number 1.0 Date 07.05.0808 Study Title A phase-II clinical trial for assessing the clinical impact of a global strategy utilizing early FDG-PET imaging for a risk-adapted therapy in untreate...

Eligibility Criteria

Inclusion

  • Patients with advanced classical Hodgkin Lymphoma according to the World Health Organization classification
  • Aged 18-60
  • Not previously treated
  • Stages IIB to IV B
  • All IPS prognostic groups
  • Patients who have signed an informed consent form

Exclusion

  • Patients aged more than 60.
  • Concomitant or previously treated neoplastic disorder less than 5 year before the diagnosis of Hodgkin's lymphoma.
  • Psychiatric disorders
  • Uncontrolled infectious disease
  • Impaired cardiac (EF \< 50%) , renal (creatinine clearance \< 60 ml/m)
  • HIV, HBV DNA, HCV RNA positive markers
  • Pregnancy and lactation
  • Patients with uncompensated diabetes mellitus and fasting glucose levels over 200 mg/dl

Key Trial Info

Start Date :

June 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2015

Estimated Enrollment :

450 Patients enrolled

Trial Details

Trial ID

NCT00795613

Start Date

June 1 2008

End Date

October 1 2015

Last Update

October 19 2015

Active Locations (24)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (24 locations)

1

The Chaim Sheba Medical Center

Tel Litwinsky, Israel

2

Ospedale S. Gerardo

Monza, Milano, Italy, 20052

3

A.O. Universitaria S. Luigi Gonzaga

Orbassano, Torino, Italy, 10043

4

A.O. Universitaria Ospedali Riuniti Osp. Umberto I

Ancona, Italy, 60100

Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL) | DecenTrialz